CDH17 and breast cancer: Furthermore, PFT-α treatment substantially increased SLUG level but decreased E-CADHERIN level (Fig. 6b), which rescued piR-36,712 overexpression-suppressed migration and invasion abilities of breast cancer cells (Fig. 6f and g, Additional file 2: Figure S5I and S5J).